Nicholas A. Smith

Array ( [id] => 7208661 [patent_doc_number] => 20050053600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Methods for treating rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 10/938673 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7216 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053600.pdf [firstpage_image] =>[orig_patent_app_number] => 10938673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182740 [patent_doc_number] => 20050191290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Means and methods for manipulating hypersensitivity-like responses' [patent_app_type] => utility [patent_app_number] => 10/936433 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10435 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191290.pdf [firstpage_image] =>[orig_patent_app_number] => 10936433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982824 [patent_doc_number] => 20050152894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Antibodies with altered effector functions' [patent_app_type] => utility [patent_app_number] => 10/934087 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28199 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152894.pdf [firstpage_image] =>[orig_patent_app_number] => 10934087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116220 [patent_doc_number] => 20050069521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Enhancing the circulating half-life of interleukin-2 proteins' [patent_app_type] => utility [patent_app_number] => 10/928305 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10878 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069521.pdf [firstpage_image] =>[orig_patent_app_number] => 10928305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168344 [patent_doc_number] => 20050202010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor' [patent_app_type] => utility [patent_app_number] => 10/927494 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 39623 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202010.pdf [firstpage_image] =>[orig_patent_app_number] => 10927494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120912 [patent_doc_number] => 20070142627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Sugar-chain-altered anti-hm1.24 antibody' [patent_app_type] => utility [patent_app_number] => 10/567856 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6482 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142627.pdf [firstpage_image] =>[orig_patent_app_number] => 10567856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 655200 [patent_doc_number] => 07109304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'Humanized anti-CD19 antibodies' [patent_app_type] => utility [patent_app_number] => 10/903858 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22630 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109304.pdf [firstpage_image] =>[orig_patent_app_number] => 10903858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010798 [patent_doc_number] => 20050064514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Identification and engineering of antibodies with variant Fc regions and methods of using same' [patent_app_type] => utility [patent_app_number] => 10/902588 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 93404 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064514.pdf [firstpage_image] =>[orig_patent_app_number] => 10902588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252417 [patent_doc_number] => 20040259207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Polynucleotide and polypeptide sequences of canine cathepsin S' [patent_app_type] => new [patent_app_number] => 10/894106 [patent_app_country] => US [patent_app_date] => 2004-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15916 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259207.pdf [firstpage_image] =>[orig_patent_app_number] => 10894106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211820 [patent_doc_number] => 20050054046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Non-human primate Fc receptors and methods of use' [patent_app_type] => utility [patent_app_number] => 10/896840 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26989 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054046.pdf [firstpage_image] =>[orig_patent_app_number] => 10896840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613561 [patent_doc_number] => 07989594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Modified antibody fab fragments' [patent_app_type] => utility [patent_app_number] => 10/562746 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8589 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989594.pdf [firstpage_image] =>[orig_patent_app_number] => 10562746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317580 [patent_doc_number] => 20040224357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Human parotid secretory protein' [patent_app_type] => new [patent_app_number] => 10/870048 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23499 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224357.pdf [firstpage_image] =>[orig_patent_app_number] => 10870048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103972 [patent_doc_number] => 20050106698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Recombinant kid pregastric esterase and methods for its production and use' [patent_app_type] => utility [patent_app_number] => 10/870399 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11257 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106698.pdf [firstpage_image] =>[orig_patent_app_number] => 10870399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5224700 [patent_doc_number] => 20070253966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 10/558862 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9786 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253966.pdf [firstpage_image] =>[orig_patent_app_number] => 10558862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823802 [patent_doc_number] => 07405274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Connective tissue growth factor antibodies' [patent_app_type] => utility [patent_app_number] => 10/858186 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27877 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405274.pdf [firstpage_image] =>[orig_patent_app_number] => 10858186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999338 [patent_doc_number] => 20070041972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Antibodies and fusion proteins that include engineered constant regions' [patent_app_type] => utility [patent_app_number] => 10/559085 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 10078 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041972.pdf [firstpage_image] =>[orig_patent_app_number] => 10559085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925390 [patent_doc_number] => 20050238645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method and composition for altering a B cell mediated pathology' [patent_app_type] => utility [patent_app_number] => 10/843703 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 23020 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 64 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238645.pdf [firstpage_image] =>[orig_patent_app_number] => 10843703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7810956 [patent_doc_number] => 08133486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Method and composition for altering a B cell mediated pathology' [patent_app_type] => utility [patent_app_number] => 10/842953 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 12 [patent_no_of_words] => 23088 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133486.pdf [firstpage_image] =>[orig_patent_app_number] => 10842953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7183192 [patent_doc_number] => 20040203052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/837625 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18741 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203052.pdf [firstpage_image] =>[orig_patent_app_number] => 10837625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341431 [patent_doc_number] => 20040191244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => new [patent_app_number] => 10/835642 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40505 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191244.pdf [firstpage_image] =>[orig_patent_app_number] => 10835642 [rel_patent_id] =>[rel_patent_doc_number] =>)